Skip to main content
. Author manuscript; available in PMC: 2016 Oct 31.
Published in final edited form as: Clin Infect Dis. 2015 Aug 30;62(1):90–98. doi: 10.1093/cid/civ708

Table 2.

Percentagea of Patients Prescribed Antiretroviral Therapy and Virally Suppressed: By Patient Characteristics Among Those With Healthcare Coverage or Assistance, Medical Monitoring Project, 2009–2013 (n = 17 560)

Prescribed ART (%)b HIV Viral Load Undetectable or <200 copies/mL (%)
Characteristic % 95% CI P Valuec % 95 % CI P Valuec
Health care payer type <.01 <.01
 RWHAP only 94.2 92.8 95.5 76.7 74.5 78.8
 Private 88.5 87.3 89.8 79.4 77.5 81.2
 Medicaid 88.8 87.3 90.3 65.7 63.2 68.2
 Medicare 92.6 90.3 94.9 78.0 75.0 81.0
 Medicaid +Medicare 93.9 92.7 95.1 76.0 73.8 78.3
 Other public 88.7 83.3 94.2 73.6 67.7 79.5
 Private+RWHAP 95.2 93.3 97.1 82.4 79.3 85.5
 Medicaid+RWHAP 94.9 93.6 96.3 70.4 67.3 73.4
 Medicare+RWHAP 96.3 95.0 97.7 82.2 79.1 85.3
 Medicaid+Medicare+RWHAP 96.4 94.7 98.2 80.0 76.0 84.0
 Other public + RWHAP 95.4 92.8 97.9 78.8 74.4 83.2
 VA/Champus/Tricare 95.2 92.7 97.8 79.4 74.9 83.9
 Other payer type 92.4 90.7 94.0 77.3 74.7 80.0
Gender   .02 <.01
 Male 92.6 91.9 93.3 77.6 76.4 78.8
 Female 91.2 90.3 92.1 71.1 69.2 73.0
 Transgender/Intersex 93.6 90.0 97.2 67.5 60.4 74.6
Age (years) <.01 <.01
 18–29 82.5 79.7 85.3 62.2 59.3 65.2
 30–39 90.7 89.3 92.1 70.9 68.9 72.9
 40–49 92.7 91.8 93.6 74.8 73.2 76.3
 ≥50 94.1 93.3 94.9 80.7 79.5 82.0
Race/Ethnicity <.01 <.01
 non-Hispanic black 91.2 90.3 92.1 70.1 68.4 71.8
 non-Hispanic white 93.5 92.4 94.6 81.9 80.8 82.9
 Hispanic 92.3 91.1 93.4 76.4 74.1 78.8
 Other 91.8 90.0 93.7 76.5 73.2 79.7
Nativity   .31   .03
 US-born 92.2 91.6 92.7 75.4 74.2 76.6
 Foreign-born 92.8 91.5 94.1 78.1 75.7 80.5
Education   .33 <.01
 Less than high school 92.8 92.0 93.6 70.3 68.4 72.2
 High school graduated 92.0 91.1 92.9 74.0 72.6 75.4
 Some college or more 92.1 91.4 92.9 78.8 77.6 80.1
Poverty statuse   .07 <.01
 Above poverty level 92.7 91.9 93.4 80.2 79.1 81.3
 At or below poverty level 91.9 91.2 92.6 70.4 68.7 72.1
Homeless (past 12 mo)f <.01 <.01
 Yes 89.4 87.5 91.3 62.0 58.8 65.1
 No 92.5 91.9 93.1 77.0 75.8 78.1
Time since HIV diagnosis (years) <.01 <.01
 <5 86.8 85.4 88.2 72.4 70.3 74.6
 5–9 92.9 91.9 93.9 76.1 74.5 77.8
 10+ 94.0 93.3 94.8 76.9 75.5 78.2
HIV disease stageg <.01   .22
 Stage 1: No AIDS and nadir CD4 ≥500 (or CD4% ≥29) 79.5 76.9 82.0 77.9 75.1 80.6
 Stage 2: No AIDS and nadir CD4 200–499 (or CD4% 14–<29) 87.0 85.7 88.2 75.0 73.2 76.7
 Stage 3: AIDS or nadir CD4 0–199 (or CD4% <14) 95.6 94.9 96.2 76.2 74.9 77.6
Total 92.2 91.6 92.8 75.8 74.6 76.9

Abbreviations: ART, antiretroviral therapy; CI, confidence interval; HIV, human immunodeficiency virus; RWHAP, Ryan White HIV/AIDS Program.

a

Percentages and 95 CIs are weighted to account for unequal selection probabilities and nonresponse.

b

Documented ART prescription in the medical record during the 12 months prior to interview.

c

P-value corresponding to global F-test.

d

Includes general education development (GED) credential.

e

US Department of Health and Human Services. Available at: http://aspe.hhs.gov/poverty/09poverty.shtml.

f

McKinney-Vento definition of homelessness: living on the street, living in a shelter, living in a single-room-occupancy hotel, temporarily staying with friends or family, or living in a car. A person is categorized as homeless if that person lacks a fixed, regular, adequate night-time residence or has a steady night-time residence that is 1) a supervised publicly or privately operated shelter designed to provide temporary living accommodation, 2) an institution that provides a temporary residence for persons intended to be institutionalized, or 3) a public or private place not designed for or ordinarily used as a regular sleeping accommodation for human beings (eg, in an automobile or under a bridge) (Stewart B. McKinney Homeless Assistance Act, 42 U.S.C. §11301, et seq; 1987).

g

Schneider E, Whitmore S, Glynn KM, et al Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years—United States, 2008. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. Dec 5 2008; 57(RR-10):1–12.